Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page has removed a citation regarding a study on Tislelizumab versus chemotherapy for esophageal squamous cell carcinoma, which included details about the study's authors and publication.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of tislelizumab for treating advanced esophageal squamous cell carcinoma (ESCC), while a new version number has been added.SummaryDifference9%
Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.